Skip to main content
See every side of every news story
Published • loading... • Updated

CRISPR Assay Detects Cell-Free DNA to Diagnose Tuberculous Pleurisy

Summary by BIOENGINEER.ORG
A prospective evaluation demonstrates that a CRISPR-Cas13a assay targeting cell-free bacterial DNA in pleural effusion supernatant achieves 80.5 percent diagnostic sensitivity for tuberculous pleurisy.
DisclaimerThis story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.

Bias Distribution

  • There is no tracked Bias information for the sources covering this story.

Factuality Info Icon

To view factuality data please Upgrade to Premium

Ownership

Info Icon

To view ownership data please Upgrade to Vantage

BIOENGINEER.ORG broke the news on Thursday, November 12, 2026.
Too Big Arrow Icon
Sources are mostly out of (0)
News
Feed Dots Icon
For You
Search Icon
Search
Blindspot LogoBlindspotLocal